Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 138 of 200 Β· By data quality, then INN

  1. talimogene laherparepvec

    IMLYGIC

    EMA: approved

    L01XX51
  2. talquetamab

    TALVEY

    EMA: approved

    L01FX29
  3. tanezumab

    RAYLUMIS

    EMA: refused

    N02
  4. tarlatamab

    IMDYLLTRA

    EMA: unknown

    L01FX33
  5. tasonermin

    BEROMUN

    EMA: approved

    L03AX11
  6. tebentafusp

    KIMMTRAK Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    L01XX75
  7. teclistamab

    TECVAYLI

    EMA: approved

    L01F
  8. tecovirimat monohydrate

    TECOVIRIMAT SIGA

    EMA: approved

    J05AX24
  9. tegafur

    TEYSUNO

    EMA: approved

    L01BC53
  10. tegaserod

    ZELNORM

    EMA: refused

    A03AE02
  11. tegomil fumarate

    RIULVY

    EMA: approved

    L04AX10
  12. telotristat ethyl

    XERMELO

    EMA: approved

    A16A
  13. temoporfin

    FOSCAN

    EMA: approved

    L01XD05
  14. tenecteplase

    METALYSE

    FDA: approved Β· EMA: approved

    B01AD11
  15. tenofovir disoproxil

    TENOFOVIR ARX Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved

    J05AF07
  16. teplizumab

    TEIZEILD

    EMA: approved Β· NMPA: clinical trials

    A10XX01
  17. tepotinib

    TEPMETKO Merck KGaA, Darmstadt, Germany

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EX21
  18. teprotumumab

    TEPEZZA

    EMA: approved

    L04AG13
  19. tesamorelin

    EGRIFTA

    EMA: application withdrawn Β· NMPA: clinical trials

  20. tezepelumab

    TEZSPIRE

    EMA: approved

    R03DX11
  21. thrombin alfa

    RECOTHROM

    EMA: application withdrawn

  22. tilmanocept

    LYMPHOSEEK

    EMA: withdrawn

    V09IA09
  23. tiratricol

    EMCITATE

    EMA: approved

    H03AA04
  24. tisagenlecleucel

    KYMRIAH

    EMA: approved

    L01XL04

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.